aerd.partners.orgAspirin Exacerbated Respiratory Disease – at Brigham and Women's Hospital – A Teaching Affiliate of
aerd.partners.org Profile
aerd.partners.org
Maindomain:partners.org
Title:Aspirin Exacerbated Respiratory Disease – at Brigham and Women's Hospital – A Teaching Affiliate of
Description:Home About Us Mission About AERD Aspirin Desensitization Research PATIENT REGISTRY – AERD/Samter’s Triad Patient Registry CLINICAL TRIAL – Mechanisms of aspirin desensitization and high-dose asp
Discover aerd.partners.org website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
aerd.partners.org Information
Website / Domain: |
aerd.partners.org |
HomePage size: | 40.022 KB |
Page Load Time: | 0.120132 Seconds |
Website IP Address: |
170.223.178.101 |
Isp Server: |
Partners Healthcare System Inc. |
aerd.partners.org Ip Information
Ip Country: |
United States |
City Name: |
Boston |
Latitude: |
42.341869354248 |
Longitude: |
-71.09684753418 |
aerd.partners.org Keywords accounting
aerd.partners.org Httpheader
Date: Fri, 14 Feb 2020 14:19:28 GMT |
Server: Apache |
X-Powered-By: PHP/5.6.40, PleskLin |
X-UA-Compatible: IE=edge |
Link: http://aerd.partners.org/wp-json/; rel="https://api.w.org/", http://aerd.partners.org/; rel=shortlink |
Keep-Alive: timeout=5, max=100 |
Connection: Keep-Alive |
Transfer-Encoding: chunked |
Content-Type: text/html; charset=UTF-8 |
aerd.partners.org Meta Info
charset="utf-8"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
content="Total WordPress Theme 3.5.2" name="generator" |
content="Powered by Visual Composer - drag and drop page builder for WordPress." name="generator"/ |
170.223.178.101 Domains
aerd.partners.org Similar Website
Domain |
WebSite Title |
aerd.partners.org | Aspirin Exacerbated Respiratory Disease – at Brigham and Women's Hospital – A Teaching Affiliate of |
abctrial.org | Home | Aspirin for Breast Cancer Trial |
edge.papercutpm.com | The Papercut Project Manager | Get me an aspirin, it's going to be a long night. |
papercutpm.com | The Papercut Project Manager | Get me an aspirin, it's going to be a long night. |
respiratory.advil.com | Advil Respiratory Products | Advil Respiratory |
rc.rcjournal.com | Respiratory Care |
apps.nbrc.org | The National Board for Respiratory Care |
nationaljewish.org | The Leading Respiratory Hospital in the Nation |
erj.ersjournals.com | Home | European Respiratory Society |
c.aarc.org | American Association for Respiratory Care |
njhealth.org | The Leading Respiratory Hospital in the Nation |
ersjournals.com | Home European Respiratory Society |
saasta.byu.edu | Brigham Young University |
bcpl.lib.ut.us | Brigham City Library |
board.nbrc.org | Home - The National Board for Respiratory Care |
aerd.partners.org Traffic Sources Chart
aerd.partners.org Alexa Rank History Chart
aerd.partners.org Html To Plain Text
Home About Us Mission About AERD Aspirin Desensitization Research PATIENT REGISTRY – AERD/Samter’s Triad Patient Registry CLINICAL TRIAL – Mechanisms of aspirin desensitization and high-dose aspirin treatment CLINICAL TRIAL – Therapeutic Control of Aspirin Exacerbated Respiratory Disease with Ifetroban Contact Us Search Submit What is AERD/Samter’s Triad? Aspirin Exacerbated Respiratory Disease (AERD), also known as Samter’s Triad or Aspirin Sensitive Asthma, is a chronic medical condition that consists of asthma, recurrent sinus disease with nasal polyps, and a sensitivity to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs). Approximately 10% of all adults with asthma and 40% of patients with asthma and nasal polyps are sensitive to aspirin and NSAIDs. What are the symptoms? Patients with AERD/Samter’s Triad usually have asthma, nasal congestion, and nasal polyps, and often do not respond to conventional treatments. Many have experienced chronic sinus infections and can lose their sense of smell. The characteristic feature of AERD/Samter’s Triad is that patients develop reactions triggered by aspirin or other NSAIDs. These reactions can include: Increased nasal congestion or stuffiness Eye watering or redness Cough, wheezing, or chest tightness Frontal headache or sensation of sinus pain Flushing and/or a rash Nausea and/or abdominal cramping General feeling of malaise, sometimes accompanied by dizziness Latest News & Information 23 Sep 19 A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease In this study , researchers at Brigham and Women’s Hospital demonstrated the feasibility and safety of a 1-day aspirin desensitization procedure. Desensitization remains the standard of treatment for patients with AERD but it has historically been time consuming—sometimes taking 2 to 3 days to complete. DeGregorio et al. showed that 41 patients successfully completed aspirin desensitization using the 1-day protocol. The protocol entails a 40.5 mg oral aspirin starting dose, 90 minute escalation time, and tolerating both a repeated provocative dose and at least 1 subsequent aspirin dose after reaction. On average, the entire protocol was completed in 9.5 hours which was less time other popular aspirin desensitization protocols. Although the study only included participants with a baseline FEV1 greater than or equal to 70%, patients with a FEV1 less than 70% have been successfully desensitized using this protocol, suggesting that it can be used for patients at higher risk. read more 18 Jun 19 New additions to the AERD Team! The AERD Center at Brigham and Women’s Hospital is happy to announce three new members to our team! Physician Assistant Jillian Bensko, research coordinator Deborah Gakpo, and lab technician Erin Lewis. After completing her undergraduate degree in Health and Exercise Studies at Skidmore, Jillian worked at the Asthma Research Center here at Brigham and Women’s as a research assistant. She then attended Providence College where she earned a Masters in Physician Assistant Study and joined our team in March of this year. In addition to providing care at the Allergy Clinic at 850 Boylston Street, Jillian will be in charge of new research projects and coordination for new patients. Deborah recently completed her undergraduate degree from Hamilton College where she double-majored in Biology and Dance & Movement Studies. She will be overseeing a number of ongoing clinical trials in addition to other research projects in AERD. Erin also attended Hamilton, where she completed her degree in Chemistry. She joined the team in the summer of 2018 and is responsible for the management, storage, and analysis of all biological samples gathered by the AERD team. read more 03 May 19 Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-Exacerbated Respiratory Disease: A Prospective Trial In a study conducted here at Brigham and Women’s, researcher Cahill et al. sought to explore the longitudinal changes in biomarkers of patient’s with AERD who take high-dose aspirin therapy. A total of 57 patients were enrolled, 42 with AERD and 15 with aspirin-tolerant asthma (ATAs). Participants with AERD were desensitized to aspirin and placed on high-dose aspirin treatment (1300 mg daily), and the control population of ATAs were given the same dose of aspirin. After 8 weeks, samples of blood and urine were collected and analyzed for known markers of Type 2 inflammation. Surprisingly, the patients with AERD showed an increase in several markers of inflammation after 8 weeks on aspirin therapy, despite reporting a decrease in nasal symptoms. The increase was not seen in patients with aspirin-tolerant asthma, suggesting that the effects of high-dose aspirin on patients with AERD may be unique to the disease. read more DONATE TO AERD RESEARCH Our research at the BWH AERD Center aims to understand more about the causes of AERD and to find better treatments. Click here to donate to AERD research at BWH AERD Awareness Day! The second annual AERD Awareness Day is September 26, 2019 — The Samter’s Society is leading efforts to fundraise for AERD research! You can learn more about the fundraiser and purchase t-shirts here. AERD Patient Registry To participate in the AERD/Samter’s Triad Patient Registry for research, click below to fill out your medical information online and answer questions specific to your symptoms and history of AERD. Link to Registry Latest News & Info Follow us for all the latest news in the area of AERD! Follow me Dr. Joshua Boyce gives Asthma Grand Rounds at Brigham and Womens Hospital on January 4, 2019. Link to Video A webinar (1 hour) led by Dr. Laidlaw on general information about AERD for patients and doctors, February 14, 2018 Link to Video Dr. Laidlaw speaks (6 minutes) on Recognition and Treatment of AERD at Brigham and Women's Hospital, February 3, 2015 Link to Video Dr. Laidlaw speaks on Novel Insights into AERD ("Grand Rounds", 1 hour), September 6, 2013 Link to video Printable AERD Handouts 2019 BWH AERD Newsletter 2018 BWH AERD Newsletter 2017 BWH AERD Newsletter 2016 BWH AERD Newsletter List of Medications to Avoid Oral Aspirin Desensitization: What to expect at BWH AERD: Guide for other physicians (by Drs. Laidlaw and White) AERD Resources Yahoo Samter's Triad Support Group Aspirin-induced Asthma (Wikipedia) Scripps Aspirin Desensitization Partners Asthma Center Research & Clinical Trials PATIENT REGISTRY – AERD/Samter’s Triad Patient Registry CLINICAL TRIAL – Mechanisms of aspirin desensitization and high-dose aspirin treatment CLINICAL TRIAL – Therapeutic Control of Aspirin Exacerbated Respiratory Disease with Ifetroban Contact Us For an appointment with Dr. Tanya M. Laidlaw or another allergist to learn more about AERD/Samter's Triad or aspirin desensitization, call (617) 525-1267. For an appointment with Dr. Neil Bhattacharyya for evaluation of nasal polyps or chronic sinusitis, call (617) 525-6540. Copyright Aspirin Exacerbated Respiratory Disease All Rights Reserved | PRIVACY POLICY...
aerd.partners.org Whois
"domain_name": "PARTNERS.ORG",
"registrar": "Network Solutions, LLC",
"whois_server": "whois.networksolutions.com",
"referral_url": null,
"updated_date": "2019-10-07 19:26:30",
"creation_date": "1995-07-08 04:00:00",
"expiration_date": "2029-07-07 04:00:00",
"name_servers": [
"ECOREXNS1.PARTNERS.ORG",
"ECOREXNS2.PARTNERS.ORG",
"OCOREXNS1.PARTNERS.ORG",
"OCOREXNS2.PARTNERS.ORG"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": "abuse@web.com",
"dnssec": "unsigned",
"name": null,
"org": "Partners HealthCare System",
"address": null,
"city": null,
"state": "MA",
"zipcode": null,
"country": "US"